drugset / Trial / NCT05098054
A Study of Soticlestat in Adults With Liver Failure Compared to Those With Normal Liver Function
Non-randomizedParallel-groupOpen-labelBasic science
Summary
The main aim is to check the effect of a single dose of soticlestat in adults with moderate or mild liver failure compared to healthy adults with normal liver function. Participants will check into the study clinic for 8 days. During the stay, one oral dose of soticlestat will be given and the participant will be monitored. The clinic staff will follow up with the participant about a week after discharge from the clinic.
Timeline
- Start
- 2021-10-29
- Primary completion
- 2022-05-31
- Completion
- 2022-06-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Soticlestat | Small molecule | 300 mg | Oral |
Indications
No indication recorded.